Biocryst Pharmaceuticals reported $16.14M in Stock for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alnylam Pharmaceuticals ALNY:US $ 78.52M 44.18M
Biocryst Pharmaceuticals BCRX:US $ 16.14M 0.35M
Chugai Pharma 4519:JP Y 225480M 16642M
Daiichi Sankyo 4568:JP Y 217910M 6304M
Gilead Sciences GILD:US $ 2675M 1057M
GlaxoSmithKline GSK:LN 6003M 220M
Intra Cellular Therapies ITCI:US $ 7.89M 0.06M
IONIS PHARMACEUT IONS:US $ 24.03M 0.77M
Karyopharm Therapeutics KPTI:US $ 3.87M 232K
Neurocrine Biosciences NBIX:US $ 29M 1.5M
Novavax NVAX:US $ 0 0
Ptc Therapeutics PTCT:US $ 15.28M 0.57M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M
Sarepta Therapeutics SRPT:US $ 199M 12.78M
Ultragenyx Pharmaceutical RARE:US $ 17.81M 1.58M
Vertex Pharmaceuticals VRTX:US $ 338.9M 14.2M
YTE INCY:US $ 35.46M 7.55M